CONCORD BIOTECH LT...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO CONCORD BIOTECH LT...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Concord Biotech Ltd.

Concord Biotech Ltd.

NSE & BSE · Mainboard IPO
Listed NSE & BSE Mainboard Live Chart
Issue Price
₹741
₹741
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹741
Based on GMP
Min. Investment
₹14,820
1 lot × 20 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
04 Aug 2023
Close Date
08 Aug 2023
Allotment
11 Aug 2023
Listing Date
18 Aug 2023
Exchange
NSE & BSE
Price Band
₹741
Listing Price
See chart
Allotment Status
Price Band
₹741
Per share
Face Value
₹1 per share
 
Lot Size
20 Shares
per lot
Issue Size
2,09,25,652 shares (aggregating up to ₹1,550.52 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹14,820
1 lot
Post-IPO Holding
10,46,16,204 shares
Promoters
P/E (Pre)
32.29x
 
EPS (Pre)
₹20.79
 
UPI Deadline
2023-08-08
Mandate
Anchor AllotmentThu, 03 Aug 2023
Basis of AllotmentFri, 11 Aug 2023
Refund InitiationMon, 14 Aug 2023
Demat CreditThu, 17 Aug 2023
Listing DayFri, 18 Aug 2023
UPI Mandate Deadline2023-08-08
Sale TypeOffer For Sale
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Concord Biotech Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 08 Aug 2023.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
20,925,652
100% ₹1,550.59
IPO Shares Offered
Concord Biotech Ltd. IPO total issue size: ₹1,550.59 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Total 20,925,652 ₹1,550.59
100.00%
* Based on upper price band ₹741 per share
Lot Size & Investment
Lot Size
20
Shares per Lot
Issue Price
₹741.00
Upper Band
Min Investment
₹14,820
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)240₹29,640
Retail (Max — 13 Lots)13260₹192,660
S-HNI (Min — 14 Lots)14280₹207,480
B-HNI (Min — 68 Lots)681,360₹1,007,760
* Issue Price ₹741 × Lot Size 20 shares
IPO Schedule
Anchor
03 Aug 2023
✓ Done
IPO Open
04 Aug 2023
✓ Done
IPO Close
08 Aug 2023
✓ Done
Allotment
11 Aug 2023
✓ Done
Refunds
14 Aug 2023
✓ Done
Demat Credit
17 Aug 2023
✓ Done
Listing Day
18 Aug 2023
✓ Done
Concord Biotech Ltd. — Live Price LIVE
₹741.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹741.00 Live Price
About Concord Biotech Ltd.
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Concord Biotech Ltd. Financials (Amount in Crore)
Revenue from Operations
₹888.5
31 Mar 2023
₹736.4
31 Mar 2022
₹630.8
31 Mar 2021
Profit After Tax (PAT)
₹240.1
31 Mar 2023
₹174.9
31 Mar 2022
₹234.9
31 Mar 2021
Particulars31 Mar 202131 Mar 202231 Mar 2023
Revenue from Operations 630.75 736.35 888.48
EBITDA N/A N/A N/A
Profit After Tax (PAT) 234.89 174.93 240.08
Net Worth 999.37 1103.22 1290.00
Total Assets 1182.55 1312.80 1513.98
Reserves & Surplus N/A N/A N/A
Borrowings 86.35 60.59 31.24
EBITDA Margin (%) N/A
PAT Margin (%) N/A
RoE
20.06%
RoCE
24.27%
RoNW
20%
Issue Structure & Shareholding
Total Shares Offered2,09,25,652 (100.00%)
Net Offer to PublicN/A
Reserved for Market MakerN/A
Pre-Issue Promoter HoldingN/A
Post-Issue Promoter Holding10,46,16,204 shares
P/BV RatioN/A
RoE20.06%
RoCE24.27%
Debt / EquityN/A
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Kotak Mahindra Capital Co.Ltd.
Citigroup Global Markets India Pvt.Ltd.
Jefferies India Pvt.Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Concord Biotech Ltd. IPO subscribed?

Concord Biotech Ltd. IPO is subscribed 1.00 times by Aug 08, 2023. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Concord Biotech Ltd. IPO retail subscription status?

The Concord Biotech Ltd. IPO retail category is subscribed 1.00 times as of 08 Aug 2023. The retail portion is oversubscribed.

How to subscribe Concord Biotech Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 04 Aug 2023 and closes 08 Aug 2023. Min investment: ₹14,820 (1 lot = 20 shares). UPI mandate: 2023-08-08.

How many times Concord Biotech Ltd. IPO subscribed?

The Concord Biotech Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Concord Biotech Ltd. IPO allotment?

Check allotment on the registrar website (MUFG Intime India Pvt.Ltd.) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 11 Aug 2023. Refunds: on 14 Aug 2023.

When Concord Biotech Ltd. IPO will be listed?

The Concord Biotech Ltd. IPO listing date is 18 Aug 2023, Friday. Listed on: NSE & BSE. Issue price: ₹741. Estimated listing: ₹741. GMP: NIL.

When Concord Biotech Ltd. IPO close?

The Concord Biotech Ltd. IPO closes on 08 Aug 2023, Tuesday. UPI mandate: 2023-08-08. Allotment: 11 Aug 2023. Listing: 18 Aug 2023.